Table 3.
Treatment received during admission in groups of heart failure patients with and without COPD.
| Variable | HF with COPD (n = 812) |
HF without COPD (n = 2288) |
p |
|---|---|---|---|
| Non-invasive mechanical ventilation n (%) | 62 (7.6%) | 105 (4.6%) | 0.004 |
| High Flow oxygen n (%) | 74/529 (14%) | 229/2014 (11.4%) | 0.018 |
| Nitroglicerine iv | 69/805(86%) | 237/2281(20.4%) | 0.222 |
| Hypertonic saline + furosemide n (%) | 15/536 (2.8%) | 34/1495 (2.3%) | 0.297 |
| Furosemide perfusion n (%) | 138/812 (17%) | 364/2288 (15.9%) | 0.770 |
| Use of amines n (%) | 50/812 (6.2%) | 110/2288 (4.8%) | 0.326 |
| Levosimendan n (%) | 11/812 (1.4%) | 23/2288 (1%) | |
| Dialysis n (%) | 6/536 (1.1%) | 17/1493 (1.1%) | 1.000 |
| Oral morphine n (%) | 151/536 (28.2%) | 379/1497 (25.3%) | 0.109 |
| Subcutaneous morphine n (%) | 74/472 (15.7%) | 223/1304 (17.1%) | 0.263 |
| Benzodiazepines n (%) | 185/535 (34.6%) | 496/1496 (33.2%) | 0.292 |